本次停产检修是根据年度计划进行的例行检修，对公司的生产经营不会产生 影响。 特此公告。 万华化学集团股份有限公司 2023 年 8 月 12 日 证券代码：600309 证券简称：万华化学 公告编号：临 2023-54 号 万华化学集团股份有限公司 烟台产业园 MDI 一体化、石化一体化等装置停产检修公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据化工企业生产工艺特点，为确保生产装置安全有效运行，按照年度检修 计划，公司烟台产业园 MDI 一体化（主要包括 MDI 110 万吨/年、TDI 30 万吨/ 年）、石化一体化（主要包括 PDH 75 万吨/年、PO/MTBE 24/76 万吨/年）及相关 配套装置将于 2023 年 8 月 15 日开始停产检修，预计检修 40 天左右。 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥87.63 billion, a decrease of 1.67% compared to ¥89.12 billion in the same period last year[16]. - The net profit attributable to shareholders for the first half of 2023 was ¥8.57 billion, down 17.48% from ¥10.38 billion year-on-year[16]. - The net cash flow from operating activities was ¥11.22 billion, representing a decline of 21.43% compared to ¥14.28 billion in the previous year[16]. - The basic earnings per share for the first half of 2023 were ¥2.73, a decrease of 17.52% from ¥3.31 in the same period last year[19]. - The weighted average return on equity decreased by 4.01 percentage points to 10.63% compared to 14.64% in the previous year[19]. - The company reported a net loss of 17,110,217 RMB for the first half of 2023[79]. - Total revenue for the period was 173,525,229 RMB, indicating a significant scale of operations[79]. - The company reported a significant investment income of ¥827,065,220.93, a sharp decline from ¥15,603,978,046.76 in the same period last year[92]. - The total comprehensive income for the first half of 2023 was ¥6,152,878,664.23, a decrease of 69.7% compared to ¥20,263,912,603.45 in the previous year[94]. Assets and Liabilities - The total assets at the end of the reporting period were ¥245.24 billion, an increase of 22.11% from ¥200.84 billion at the end of the previous year[18]. - The total liabilities increased to ¥158.56 billion from ¥119.51 billion, representing a rise of 32.7%[85]. - The company's total assets at the end of the first half of 2023 are approximately CNY 45.66 billion, compared to CNY 38.02 billion at the end of 2022, showing an increase of about 20.2%[104]. - The company's total liabilities at the end of the first half of 2023 are approximately CNY 38.02 billion, reflecting a growth from CNY 33.25 billion at the end of 2022[104]. - Total current assets increased to ¥72.62 billion as of June 30, 2023, up from ¥51.53 billion at the end of 2022, representing a growth of 40.8%[83]. - Total non-current assets amounted to ¥172.62 billion, up from ¥149.31 billion, indicating a growth of 15.6%[84]. Cash Flow - The company reported a significant increase of 1,087.07% in net cash flow from financing activities, amounting to approximately ¥24.51 billion, compared to a negative cash flow of ¥2.48 billion in the previous year[35]. - The company reported a net cash flow from operating activities for the first half of 2023 was approximately ¥9.36 billion, a significant increase from ¥2.65 billion in the same period of 2022, representing a growth of 253%[99]. - Cash inflow from financing activities amounted to approximately ¥48.71 billion, up from ¥25.11 billion in the same period last year, indicating a growth of 94%[100]. - The ending balance of cash and cash equivalents as of June 30, 2023, was approximately ¥14.66 billion, up from ¥13.50 billion at the end of the first half of 2022[100]. Investments and Acquisitions - The company completed the acquisition of Yantai Jieli Fine Chemical Co., enhancing its competitive position in the TDI industry in the northwest region[31]. - The company is actively expanding its fine chemicals business, with the launch of the bisphenol A project improving market share and profitability[31]. - The company made external equity investments totaling ¥69.72 million during the reporting period, with significant investments in renewable energy and battery manufacturing[41]. Research and Development - Research and development expenses increased by 17.06% to approximately ¥1.79 billion, compared to ¥1.53 billion in the previous year[35]. - The company applied for 363 domestic and international invention patents and obtained 473 new invention patent authorizations in the first half of 2023[34]. - The company is focusing on enhancing safety and cost control through collaborative efforts and employee engagement in micro-innovation initiatives[32]. Environmental and Social Responsibility - The company is committed to green development and aims to create greater value for customers, employees, and shareholders[26]. - The company has implemented strict environmental protection measures during the construction of pollution prevention facilities, ensuring compliance with the "three simultaneities" principle[57]. - The company has initiated a comprehensive smart energy project, which is expected to save approximately 2.6 million tons of coal and reduce CO2 emissions by 6.7 million tons annually[65]. Corporate Governance - The company held its annual shareholders' meeting on May 12, 2023, where 17 proposals, including the financial settlement report for 2022, were approved[49]. - The company completed the election of its ninth board of directors and supervisory board, appointing a new management team[51]. - There were no significant lawsuits or arbitration matters during the reporting period[71]. Shareholder Information - The total number of common shareholders as of the end of the reporting period is 128,218[77]. - The largest shareholder, Yantai Guofeng Investment Holding Group Co., Ltd., holds 21.59% of the shares, totaling 677,764,654 shares[78]. - The company has not experienced any changes in its total share capital or share structure during the reporting period[77]. Compliance and Accounting - The financial statements comply with the requirements of the accounting standards, accurately reflecting the company's financial position as of June 30, 2023[110]. - The company adheres to the accounting policies and estimates that reflect its operational characteristics, including methods for credit risk loss provisions and inventory valuation[109]. - The group recognizes revenue based on whether it has control over the goods or services before transferring them to customers, confirming revenue at the total consideration received or receivable if acting as the principal[175].

Financial Performance - The company's operating revenue for Q1 2023 was CNY 41.94 billion, an increase of 0.37% year-on-year[4] - The net profit attributable to shareholders was CNY 4.05 billion, a decrease of 24.58% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 3.99 billion, down 25.40% year-on-year[4] - The basic earnings per share for Q1 2023 was CNY 1.29, a decrease of 24.56% compared to the previous year[4] - The weighted average return on equity was 5.14%, a decrease of 2.41 percentage points year-on-year[4] - The net profit for Q1 2023 was CNY 4,388,675,818.16, a decrease of 20.5% compared to CNY 5,522,423,077.31 in Q1 2022[18] - The total profit for Q1 2023 was CNY 4,932,207,982.00, down from CNY 6,444,507,361.51 in the same period last year, representing a decline of 23.4%[18] - Operating profit for Q1 2023 was CNY 5,000,467,008.56, compared to CNY 6,455,861,361.40 in Q1 2022, reflecting a decrease of 22.5%[18] - The total comprehensive income for Q1 2023 was CNY 4,427,089,949.54, compared to CNY 5,427,370,443.93 in Q1 2022, a decrease of 18.4%[19] - Basic earnings per share for Q1 2023 were CNY 1.29, down from CNY 1.71 in Q1 2022, a decline of 24.6%[19] - The company reported a net profit margin improvement, with net profit for Q1 2023 expected to be higher than the previous quarter, although specific figures were not disclosed[16] Assets and Liabilities - Total assets at the end of Q1 2023 were CNY 237.79 billion, an increase of 18.40% from the end of the previous year[5] - The equity attributable to shareholders at the end of Q1 2023 was CNY 80.94 billion, up 5.33% from the end of the previous year[5] - Total assets reached ¥237,793,786,466.24 as of March 31, 2023, compared to ¥200,843,198,875.15 at the end of 2022, indicating an increase of about 18.4%[15] - Total liabilities increased to ¥152,019,007,279.10 in Q1 2023 from ¥119,506,211,213.71 in Q4 2022, reflecting a growth of approximately 27.2%[15] - The company's equity attributable to shareholders rose to ¥80,936,993,361.58 in Q1 2023, up from ¥76,844,533,840.41 in Q4 2022, indicating an increase of about 5.5%[15] - Short-term borrowings increased to ¥70,482,269,553.70 in Q1 2023 from ¥44,019,483,776.90 in Q4 2022, representing a significant rise of approximately 60.5%[14] - The company's total liabilities increased to RMB 70,669,216,998.10 in Q1 2023 from RMB 63,596,121,846.94 in Q1 2022, reflecting a rise of about 11.67%[26] Cash Flow - The company reported a net cash flow from operating activities of CNY 4.17 billion, an increase of 2.87% year-on-year[4] - Cash flow from operating activities in Q1 2023 was CNY 39,676,626,031.49, down from CNY 50,255,573,437.34 in Q1 2022, a decline of 21.0%[20] - Cash flow from investing activities in Q1 2023 was -CNY 12,378,974,381.25, compared to -CNY 6,097,272,417.58 in Q1 2022, indicating an increase in cash outflow[21] - Cash flow from financing activities in Q1 2023 was CNY 27,203,989,598.58, significantly higher than CNY 8,347,480,310.17 in Q1 2022, showing an increase of 226.5%[22] - The company received CNY 26,244,060,000.00 in cash from borrowings during Q1 2023, compared to CNY 16,940,052,445.31 in Q1 2022[30] Costs and Expenses - Total operating costs for Q1 2023 were ¥37,073,968,523.25, up from ¥35,375,721,001.55 in Q1 2022, indicating an increase of about 4.79%[16] - Research and development expenses rose to ¥868,730,813.99 in Q1 2023, compared to ¥795,771,505.23 in Q1 2022, reflecting an increase of approximately 9.3%[16] - The company's R&D expenses for Q1 2023 were RMB 641,370,582.44, compared to RMB 592,842,106.93 in Q1 2022, indicating an increase of approximately 8.16%[27] - The cost of goods sold decreased to RMB 10,327,946,019.66 in Q1 2023 from RMB 10,527,630,105.46 in Q1 2022, a reduction of about 1.89%[27] Operational Changes - The company faced a decline in product prices, which significantly impacted net profit[7] - The company is actively responding to changes in the operating environment by enhancing its global supply chain layout and increasing production capacity[10] Cash and Cash Equivalents - The company's cash and cash equivalents amounted to ¥37,977,274,148.77 as of March 31, 2023, significantly higher than ¥18,988,842,959.88 at the end of 2022, marking an increase of about 99.5%[11] - The cash and cash equivalents at the end of Q1 2023 were CNY 37,807,472,153.55, compared to CNY 40,237,092,912.72 at the end of Q1 2022, a decrease of 6.0%[22] - The company reported a foreign exchange impact on cash and cash equivalents of CNY 3,307,844.59 in Q1 2023, contrasting with a negative impact of CNY -77,797,309.11 in Q1 2022[22] - Cash and cash equivalents rose significantly to RMB 13,049,353,299.13 in Q1 2023 from RMB 6,179,613,676.25 in Q1 2022, marking an increase of approximately 110.38%[25] - The company's cash and cash equivalents at the end of Q1 2023 totaled CNY 13,034,802,452.42, compared to CNY 13,675,516,126.91 at the end of Q1 2022[30]

证券代码：600309 证券简称：万华化学 公告编号：临 2023-25 号 万华化学集团股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资者可于 2023 年 04 月 03 日至 04 月 10 日 16:00 前登录上证路演中心网站首页点击"提 问预征集"栏目或通过公司邮箱 stocks@whchem.com 进行提问。公司将在说明会上对投资者普 遍关注的问题进行回答。 万华化学集团股份有限公司（以下简称"公司"）已于 2023 年 3 月 21 日发布 公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营成 果、财务状况，公司计划于 2023 年 04 月 11 日下午 16:00-17:00 举行 2022 年度 业绩说明会，就投资者关心的问题进行交流。 三、 参加人员 会议召开时间：2023 年 04 月 11 日(星期二) 下午 16:00-17:00 会议召开地点：上海证券交易所上证路演中心（网址：ht ...

Financial Performance - The company's operating revenue for 2022 was ¥165.57 billion, an increase of 13.76% compared to ¥145.54 billion in 2021[16]. - Net profit attributable to shareholders decreased by 34.14% to ¥16.23 billion from ¥24.65 billion in 2021[16]. - Basic earnings per share dropped to ¥5.17, a decrease of 34.14% from ¥7.85 in 2021[17]. - The weighted average return on equity fell to 22.75%, down 19.78 percentage points from 42.53% in 2021[17]. - The total assets at the end of 2022 were ¥200.84 billion, reflecting a 5.53% increase from ¥190.31 billion at the end of 2021[16]. - The net assets attributable to shareholders increased by 12.18% to ¥76.84 billion from ¥68.50 billion in 2021[16]. - The company achieved a sales revenue of CNY 165.57 billion, an increase of 13.76% year-on-year[46]. - The net profit attributable to shareholders was CNY 16.23 billion, a decrease of 34.14% year-on-year, with earnings per share at CNY 5.17[46]. - The total assets at the end of 2022 amounted to CNY 200.84 billion, a year-on-year increase of 5.53%[46]. - The company's weighted average return on equity was 22.75%, a decrease of 19.78 percentage points year-on-year[46]. - The cash flow from operating activities increased by 30.14% to CNY 36.34 billion, driven by sales growth[48]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 16 CNY per 10 shares, totaling 5,023,594,601.60 CNY, based on a total share capital of 3,139,746,626 shares as of December 31, 2022[3]. - The company has a retained undistributed profit of 36,894,189,505.35 CNY to be carried forward for future distribution[3]. - The net profit attributable to ordinary shareholders for the year was 16,233,626,024.32 RMB, with a cash dividend ratio of 30.95%[126]. Audit and Compliance - Deloitte Huayong Certified Public Accountants issued a standard unqualified audit report for the company[3]. - The board of directors and senior management have ensured the authenticity, accuracy, and completeness of the annual report[2]. - The company has confirmed that there are no instances of more than half of the directors being unable to guarantee the authenticity, accuracy, and completeness of the annual report[4]. - The internal control audit report issued by Deloitte provided a standard unqualified opinion[131]. - The audit report confirmed that the financial statements were prepared in accordance with accounting standards, providing assurance of their accuracy[192]. Operational Efficiency and Strategy - The company reported a significant increase in cash flow from operating activities, indicating improved operational efficiency[16]. - The company plans to continue optimizing its global supply chain management and resource allocation to maintain steady revenue growth[22]. - The company implemented 841 cost reduction and efficiency improvement projects in 2022, enhancing its competitive advantage in low-cost, high-quality production[33]. - The company achieved a 20% improvement in material management efficiency through logistics information technology construction, effectively reducing the delivery time of procurement logistics[34]. - The company plans to strengthen project management capabilities across multiple regions, including Yantai, Penglai, Ningbo, Fujian, Sichuan, and Hungary, to improve competitiveness[95]. Research and Development - In 2022, the company applied for 1,002 domestic and international invention patents, with a 154% year-on-year increase in newly authorized patents[42]. - The company had a total R&D investment of 3.42 billion yuan in 2022, focusing on high-end chemical new materials and carbon neutrality technologies[63]. - The number of R&D personnel is 3,285, accounting for 13% of the total workforce[62]. - The company is focusing on high-end chemical new materials and fine chemicals, with ongoing R&D in high-performance engineering plastics and biodegradable plastics[73]. - The company successfully launched several new products, including high-end medical-grade PC and PMMS, with a gradually increasing market share[63]. Environmental and Social Responsibility - The company invested 153,824,000 RMB in environmental protection during the reporting period[134]. - The company has established environmental protection mechanisms and is classified as a key pollutant discharge unit[134]. - The company invested a total of 12.93 million yuan in social responsibility initiatives, focusing on poverty alleviation, education, and environmental protection[148]. - The company implemented a cherry base construction of 25 acres and village beautification projects as part of its poverty alleviation efforts[149]. - In 2022, the company successfully reduced carbon emissions by approximately 413,000 tons through the use of clean energy and other carbon reduction technologies[145]. Shareholder and Governance - The company has a total of 135,891 common stock shareholders at the end of the reporting period, an increase from 123,595 at the end of the previous month[170]. - The largest shareholder, Yantai Guofeng Investment Holding Group, holds 677,764,654 shares, representing 21.59% of total shares[171]. - The company has not faced any penalties from securities regulatory authorities in the past three years[106]. - The company has committed to resolving competition issues and related transactions with its major shareholders and affiliates, with commitments being fulfilled in a timely manner[151]. Financial Instruments and Debt Management - The company issued a total of 1,000,000,000.00 RMB in the first short-term financing bond of 2022 with an interest rate of 2.5%[182]. - The company has not experienced any overdue bonds during the reporting period[184]. - The company maintained a credit rating of AAA with a stable outlook for all issued bonds, indicating strong financial health and creditworthiness[188]. - The company has implemented measures to mitigate risks associated with the termination of bond trading[184]. Market Position and Competitive Advantage - The company ranked 17th in the 2022 Global Chemical Companies Top 50 list, a significant rise of 12 places from 2021[36]. - The company has a competitive advantage in the polyether business, becoming a core supplier in downstream industries such as home appliances, furniture, and automotive[70]. - The company aims to become a leading global chemical new materials company by implementing an integrated, related diversification, and low-cost development strategy centered on high-tech and high-value-added chemical new materials[93].

Financial Performance - The company's operating revenue for Q3 2022 was approximately ¥41.30 billion, representing a year-over-year increase of 4.14%[2] - The net profit attributable to shareholders for Q3 2022 was approximately ¥3.23 billion, a decrease of 46.35% compared to the same period last year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was approximately ¥3.17 billion, down 47.92% year-over-year[2] - The basic earnings per share for Q3 2022 was ¥1.03, reflecting a decrease of 46.07% compared to the same period last year[4] - The net profit attributable to shareholders for the first three quarters was CNY 13.61 billion, reflecting a year-on-year decline of 30%[10] - Net profit for Q3 2022 was CNY 14,234,791,838.90, a decrease of 28.4% compared to CNY 19,883,802,550.86 in Q3 2021[19] - Operating profit for Q3 2022 was CNY 16,534,385,339.71, down 30.6% from CNY 23,796,564,395.17 in Q3 2021[18] - Total comprehensive income attributable to the parent company for Q3 2022 was CNY 13,376,930,701.71, a decrease from CNY 19,298,179,941.42 in Q3 2021[20] - The total comprehensive income for the third quarter of 2022 was approximately ¥22.52 billion, compared to ¥14.58 billion in the same quarter of 2021, marking a year-over-year increase of 54.5%[28] Assets and Liabilities - The total assets at the end of Q3 2022 amounted to approximately ¥215.87 billion, an increase of 13.43% from the end of the previous year[4] - The company's total assets as of September 30, 2022, amounted to CNY 215.87 billion, up from CNY 190.31 billion at the end of 2021[14] - The company's total liabilities increased to CNY 137.89 billion from CNY 118.61 billion year-on-year[15] - The total liabilities were approximately $67.44 billion, slightly up from $67.28 billion year-over-year[25] - The total equity attributable to shareholders at the end of Q3 2022 was approximately ¥74.03 billion, an increase of 8.07% from the end of the previous year[4] - The total equity reached approximately $47.92 billion, an increase from $33.25 billion in the previous year[26] Cash Flow - The net cash flow from operating activities for the year-to-date period was approximately ¥19.94 billion, an increase of 14.08% compared to the same period last year[4] - The net cash flow from operating activities was approximately $19.94 billion, an increase from $17.48 billion year-over-year[22] - The net cash flow from financing activities was approximately $3.93 billion, a decrease from $18.92 billion year-over-year[22] - The net cash flow from operating activities was approximately ¥3.90 billion, a decrease of 70.5% compared to ¥13.20 billion in the same period of 2021[29] - The company reported a net cash inflow from investment activities of approximately ¥1.11 billion, contrasting with a net outflow of approximately ¥12.42 billion in the same period of 2021[29] Operating Costs and Expenses - The company experienced a significant increase in operating costs, which contributed to the decline in net profit for the reporting period[6] - The operating cost for the same period was CNY 114.58 billion, which is a 36.5% increase compared to CNY 83.96 billion in the previous year[16] - Total operating expenses for Q3 2022 were CNY 144,515,741,960.44, up from CNY 111,831,382,453.22 in Q3 2021[21] - Research and development expenses increased to CNY 2,444,185,254.74 in Q3 2022, up 13.7% from CNY 2,149,067,932.98 in Q3 2021[18] - Research and development expenses increased to approximately ¥1.75 billion, up 12.4% from ¥1.56 billion in the previous year[27] Market and Strategic Position - The company continues to leverage its global channel advantages to maintain sales and pricing growth across major business segments despite economic challenges[10] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[31] Investment and Income - The company reported non-recurring gains and losses totaling approximately ¥57.37 million for Q3 2022[5] - Investment income from associates for Q3 2022 was CNY 309,042,840.17, significantly higher than CNY 163,228,382.70 in Q3 2021[18] - The company's investment income surged to approximately ¥15.66 billion, more than doubling from ¥8.67 billion in the previous year[27] Inventory and Cash Management - The company's inventory as of September 30, 2022, was CNY 19.50 billion, compared to CNY 18.28 billion in the previous year, indicating a growth of 6.7%[12] - The company's cash and cash equivalents increased to CNY 35.70 billion from CNY 34.22 billion year-on-year[12] - The company's cash and cash equivalents at the end of the reporting period totaled approximately ¥15.23 billion, an increase from ¥10.43 billion at the end of the same period in 2021[30] - The company reported a net increase in cash and cash equivalents of approximately $1.40 billion, down from $15.93 billion year-over-year[22]

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥89.12 billion, representing a 31.72% increase compared to ¥67.66 billion in the same period last year[12]. - The net profit attributable to shareholders for the first half of 2022 was approximately ¥10.38 billion, a decrease of 23.26% from ¥13.53 billion in the previous year[12]. - The basic earnings per share for the first half of 2022 were ¥3.31, down 23.20% from ¥4.31 in the same period last year[13]. - The company reported a decrease of 22.53% in net profit after deducting non-recurring gains and losses, amounting to approximately ¥10.22 billion compared to ¥13.20 billion last year[12]. - The company's operating profit for the first half of 2022 was RMB 12.663 billion, a decrease of 21.55% year-on-year[20]. - The company reported a total comprehensive income of approximately ¥20.26 billion for the first half of 2022, compared to ¥12.69 billion in the same period of 2021, showing an increase of 59.5%[74]. Cash Flow and Investments - The net cash flow from operating activities increased by 28.85% to approximately ¥14.28 billion, compared to ¥11.09 billion in the same period last year[12]. - The net cash flow from operating activities increased to ¥14,283,353,016.03, up from ¥11,085,244,968.33, representing a growth of approximately 28.5% year-over-year[77]. - The net cash flow from investing activities was negative at -¥14,513,178,497.71, worsening from -¥11,809,223,672.65, indicating a decline of approximately 22.8%[78]. - The company reported a significant increase in investment income to approximately ¥15.60 billion in the first half of 2022, compared to ¥8.63 billion in the same period of 2021, reflecting an increase of 80.5%[73]. Assets and Liabilities - The total assets of the company at the end of the reporting period were approximately ¥207.30 billion, an increase of 8.93% from ¥190.31 billion at the end of the previous year[12]. - The company's total assets reached CNY 207,296,274,820.49, up from CNY 190,309,582,268.84, reflecting an increase of approximately 8.9%[64]. - Total liabilities rose to CNY 132,846,368,787.13 from CNY 118,613,915,236.74, which is an increase of approximately 11.9%[65]. - The total owner's equity at the end of the first half of 2022 was CNY 71,695,667,032.10, with a decrease of CNY 2,754,239,001.26 during the period[81]. Research and Development - Research and development expenses rose by 25.21% to ¥1.53 billion, reflecting the company's commitment to innovation and product development[22]. - The company applied for 375 domestic and international invention patents, with 319 patents granted during the first half of 2022[21]. - The company emphasizes technological innovation as its core competitive advantage, focusing on independent innovation and high-quality development[19]. Environmental and Safety Measures - The company has implemented measures to enhance process safety and risk management in its operations[31]. - The company actively promotes the construction of online monitoring systems for environmental monitoring, achieving dynamic and real-time monitoring of emissions[42]. - The company has established a comprehensive emergency response plan for environmental incidents, including safety management and environmental hazard inspections[41]. Market and Strategic Development - The company plans to expand its product supply to meet the growing demand in strategic emerging industries such as renewable energy and communication technology[18]. - The company is focused on expanding its market presence, particularly in the Americas, and enhancing its supply chain efficiency amid the ongoing pandemic[21]. - The company is actively pursuing new customer and product development, particularly in the lithium battery and biodegradable plastics sectors[21]. Financial Management and Risks - The company has not disclosed any significant risks that could adversely affect its future development strategy and operational goals during the reporting period[2]. - The company has not proposed any profit distribution or capital reserve transfer for the reporting period[34]. - The company has no significant litigation or arbitration matters during the reporting period[49]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 159,077[54]. - The largest shareholder, Yantai Guofeng Investment Holding Group Co., Ltd., holds 677,764,654 shares, accounting for 21.59% of the total shares[54]. - The company has issued short-term financing bonds with a total balance of 1 billion RMB at an interest rate of 2.50%[58]. Taxation and Compliance - The corporate income tax rate for Wanhua Chemical is 15% for high-tech enterprises and 25% for others[196]. - Wanhua Chemical's subsidiary in Ningbo is recognized as a high-tech enterprise, with a tax rate of 15% applicable until the end of 2022[197]. - The company is eligible for up to €92,534,739 (approximately ¥648,520,465) in tax credits related to new job creation and project investments as of June 30, 2022, with €35,162,961 (approximately ¥246,436,096) remaining unused[200].

Financial Performance - The company's operating revenue for 2021 reached ¥145.54 billion, a 98.19% increase compared to ¥73.43 billion in 2020[11]. - Net profit attributable to shareholders was ¥24.65 billion, reflecting a 145.47% increase from ¥10.04 billion in the previous year[11]. - The net cash flow from operating activities amounted to ¥27.92 billion, up 65.71% from ¥16.85 billion in 2020[11]. - Basic earnings per share increased to ¥7.85, a rise of 145.31% compared to ¥3.20 in 2020[12]. - The weighted average return on equity rose to 42.53%, an increase of 20.33 percentage points from 22.20% in 2020[12]. - The company's total assets at the end of 2021 were ¥190.31 billion, a 42.28% increase from ¥133.75 billion at the end of 2020[11]. - The net assets attributable to shareholders increased to ¥68.50 billion, a 40.42% rise from ¥48.78 billion in 2020[11]. - The gross profit margin for the chemical industry segment was 26.46%, an increase of 2.38 percentage points compared to the previous year[47]. - The company reported a net profit of ¥292.60 million from non-recurring gains in 2021, compared to ¥497.48 million in 2020[16]. Investments and Projects - The company launched 53 projects in 2021, with 23 of them already completed, focusing on high standards and efficiency in engineering construction[21]. - The company completed 44 major repairs and 10 key technical upgrades throughout the year, enhancing operational efficiency[21]. - The company applied for 805 domestic and international patents in 2021, with 416 granted, strengthening its intellectual property protection[26]. - The company has made significant investments in new projects, including ¥250,774.40 million for Wanhua Chemical (Fujian) Co., Ltd.[81]. - The company is expanding its production bases in Ningbo, Yantai, and Zhuhai, with ongoing projects in Fujian and Meishan, and plans to start construction in Yantai Penglai[86]. Corporate Governance and Compliance - Deloitte Huayong Certified Public Accountants issued a standard unqualified audit opinion for the financial report[2]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders and their related parties[2]. - The company has implemented measures to ensure the independence of its operations, with no significant differences from regulatory requirements[92]. - The governance structure has been continuously improved to comply with the Company Law and other regulatory standards[92]. - The company has not reported any significant changes in competition or business operations that would affect its independence[92]. Environmental and Social Responsibility - The company achieved a gold medal certification in the ECOVADIS global corporate social responsibility assessment, ranking in the top 5% of global companies[30]. - The company signed a carbon peak and carbon neutrality declaration in January 2021, committing to achieve carbon peak and carbon neutrality as part of its sustainable development strategy[127]. - The company donated over 10 million yuan to local Red Cross organizations to support medical equipment procurement during the COVID-19 pandemic[129]. - The company organized a tree planting event with over 200 participants, planting 600 trees to enhance ecological awareness among employees[126]. - The company has engaged in various social responsibility projects, including educational support in impoverished areas, contributing to the development of local communities[131]. Market and Competitive Position - The company is innovating in the new energy sector, aligning with national "dual carbon" strategies to support sustainable development[18]. - The company is expanding its C2, C3, and C4 olefin derivatives business, leveraging a 1 million tons/year ethylene and 750,000 tons/year propane dehydrogenation facility[34]. - The company has established itself as a core supplier in the downstream industries of home appliances, furniture, automotive, and coatings through its competitive advantages in the polyether business[66]. - The company ranked 29th in the 2021 global chemical companies list by C&EN, improving by 5 positions from the previous year[32]. - The company aims to create a high-quality development model in the chemical industry, driven by technological innovation and international expansion[32]. Financial Management and Shareholder Returns - The company has implemented a cash dividend policy, ensuring clear standards and ratios for shareholder returns, with a three-year shareholder return plan approved for 2021-2023[114][115]. - The board approved the shareholder return plan for 2021-2023, emphasizing a commitment to enhancing shareholder value[92]. - The company issued bonds worth 17.2 billion yuan to meet funding needs, maintaining stable ratings through proactive international rating management[30]. - The company has a total of 1,715,990,206 restricted shares, all subject to a 36-month lock-up period due to major asset restructuring transactions[147]. - The company has not proposed a cash profit distribution plan despite having positive distributable profits for shareholders[116]. Risk Management - The company has not identified any significant risks that could adversely affect its future development strategy and operational goals during the reporting period[2]. - The company faces risks related to talent supply, operational efficiency, and organizational structure as it expands its global presence[89]. - The company has not reported any significant changes in competition or business operations that would affect its independence[92]. - The company has not reported any overdue interest-bearing debts as of the end of the reporting period[164]. - The company has not disclosed any risks related to the termination of bond trading[158].